Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy

類似資料

• Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
  著者:: Quach, H, 等
  出版事項: (2009)
• A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma
  著者:: Dhodapkar, Madhav V., 等
  出版事項: (2003)
• One-Year Follow-Up of Natural Killer Cell Activity in Multiple Myeloma Patients Treated With Adjuvant Lenalidomide Therapy
  著者:: Besson, Laurie, 等
  出版事項: (2018)
• Ex-vivo analysis of human Natural Killer T cells demonstrates heterogeneity between tissues and within established CD4(+) and CD4(−) subsets
  著者:: Chan, A C, 等
  出版事項: (2013)
• Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
  著者:: Garg, Tarun K., 等
  出版事項: (2012)